Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors
Narrating Their Story: Shadow's Edge Mobile Game Use to Enhance Resilience and Identity Formation Among Adolescent and Young Adult Survivors of Cancer
1 other identifier
interventional
177
1 country
1
Brief Summary
This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
January 2, 2020
CompletedFirst Posted
Study publicly available on registry
January 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedNovember 15, 2024
November 1, 2024
1.3 years
January 2, 2020
November 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Resilience
Resilience will be measured by participant responses to the Brief Resilience Scale (BRS), a 6-item measure with response options on 5-point Likert scale ranging from "1, strongly disagree" to "5, strongly agree" and total scores ranging from 6 to 30 (higher scores indicating greater resilience).
Baseline to 14-week follow-up
Secondary Outcomes (14)
Perceived benefit and burden
Baseline to 14-week follow-up
Life meaning and purpose
Baseline to 14-week follow-up
Fatigue
Baseline to 14-week follow-up
Pain Intensity
Baseline to 14-week follow-up
Positive affect
Baseline to 14-week follow-up
- +9 more secondary outcomes
Other Outcomes (1)
Intervention satisfaction
14-weeks post-enrollment
Study Arms (2)
Immediate Game Use
EXPERIMENTALAYACS randomly assigned to this arm will immediately play the Shadow's Edge Game following enrollment for a duration of 7 weeks. Following the designated 7-week game-play period, they will continue to have access to the game. They will continue to receive all usual care health care throughout and following the study.
Wait-List Comparison Group
NO INTERVENTIONAYACS randomly assigned to this arm will begin to play the Shadow's Edge game 7 weeks following enrollment. They will continue to receive all usual health care throughout and following the study.
Interventions
6 weeks of individual, interactive game play of the Shadow's Edge mobile app.
Eligibility Criteria
You may qualify if:
- Adolescent/young adults 13-24 years of age
- Adolescent/young adult English-speaking at a second grade level
- Parent/guardian English- or Spanish-speaking at a second grade level (for participants younger than 18 years of age)
- Patients with history of hematological malignancies (e.g., acute lymphoblastic leukemia) at maintenance phase of treatment or beyond or solid tumor patients (e.g., osteosarcoma) who have completed active treatment or cancer survivors with any form of malignancy history (excluding brain tumors) and are at least 2 years post-diagnosis of the malignancy
- Consistent access to a mobile phone and/or internet service
You may not qualify if:
- Brain tumor history
- History of moderate to severe neurodevelopmental disorder (e.g., autism spectrum disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Bonnie Essner, PhD
Ann & Robert H Lurie Children's Hospital of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Psychologist
Study Record Dates
First Submitted
January 2, 2020
First Posted
January 6, 2020
Study Start
December 10, 2018
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share